Catherine Gozé1, Marie Blonski1, Guillaume Le Maistre1, Luc Bauchet1, Edouard Dezamis1, Philippe Page1, Pascale Varlet1, Laurent Capelle1, Bertrand Devaux1, Luc Taillandier1, Hugues Duffau1, Johan Pallud1. 1. Cell Biology Laboratory, CHU Gui de Chauliac Hospital, Montpellier, France (C.G.); INSERM U1051 Institut des Neurosciences de Montpellier, Montpellier, France (C.G., H.D., L.B.); Centre des Collections Biologiques Hospitalières de Montpellier (CCBH-M), CHU Gui de Chauliac Hospital, Montpellier, France (C.G.); Réseau d'Etude des Gliomes, REG, Groland, France (C.G., M.B., L.B., L.C., L.T., J.P.); Department of Neuro-Oncology, Nancy Neurological Hospital, Nancy, France (M.B., H.D., J.D.); Department of Neurosurgery, Sainte-Anne Hospital, Paris, France (G.L.M., E.D., P.P., B.D., J.P.); University Paris Descartes, Paris, France (G.L.M., E.D., P.P., P.V., B.D., J.P.); Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier, France (L.B., H.D.); Department of Neuropathology, Sainte-Anne Hospital, Paris, France (P.V.); Department of Neurosurgery, Pitié-Salpêtrière University Hospital, Paris, France (L.C.); Department of Neuro-Oncology, CHU de Poitiers, Université de Poitiers, Poitiers, France (L.T.).
Abstract
BACKGROUND: We explored whether spontaneous imaging tumor growth (estimated by the velocity of diametric expansion) and isocitrate dehydrogenase 1 (IDH1) mutation (estimated by IDH1 immunoexpression) were independent predictors of long-term outcomes of diffuse low-grade gliomas in adults. METHODS: One hundred thirty-one adult patients with newly diagnosed supratentorial diffuse low-grade gliomas were retrospectively studied. RESULTS: Isocitrate dehydrogenase 1 mutations were present in 107 patients. The mean spontaneous velocity of diametric expansion was 5.40 ± 5.46 mm/y. During follow-up (mean, 70 ± 54.7 mo), 56 patients presented a malignant transformation and 23 died. The median malignant progression-free survival and the overall survival were significantly longer in cases of slow velocity of diametric expansion (149 and 198 mo, respectively) than in cases of fast velocity of diametric expansion (46 and 82 mo; P < .001 and P < .001, respectively) and in cases with IDH1 mutation (100 and 198 mo, respectively) than in cases without IDH1 mutation (72 mo and not reached; P = .028 and P = .001, respectively). In multivariate analyses, spontaneous velocity of diametric expansion and IDH1 mutation were independent prognostic factors for malignant progression-free survival (P < .001; hazard ratio, 4.23; 95% CI, 1.81-9.40 and P = .019; hazard ratio, 2.39; 95% CI, 1.19-4.66, respectively) and for overall survival (P < .001; hazard ratio, 26.3; 95% CI, 5.42-185.2 and P = .007; hazard ratio, 17.89; 95% CI, 2.15-200.1, respectively). CONCLUSIONS: The spontaneous velocity of diametric expansion and IDH1 mutation status are 2 independent prognostic values that should be obtained at the beginning of the management of diffuse low-grade gliomas in adults.
BACKGROUND: We explored whether spontaneous imaging tumor growth (estimated by the velocity of diametric expansion) and isocitrate dehydrogenase 1 (IDH1) mutation (estimated by IDH1 immunoexpression) were independent predictors of long-term outcomes of diffuse low-grade gliomas in adults. METHODS: One hundred thirty-one adult patients with newly diagnosed supratentorial diffuse low-grade gliomas were retrospectively studied. RESULTS:Isocitrate dehydrogenase 1 mutations were present in 107 patients. The mean spontaneous velocity of diametric expansion was 5.40 ± 5.46 mm/y. During follow-up (mean, 70 ± 54.7 mo), 56 patients presented a malignant transformation and 23 died. The median malignant progression-free survival and the overall survival were significantly longer in cases of slow velocity of diametric expansion (149 and 198 mo, respectively) than in cases of fast velocity of diametric expansion (46 and 82 mo; P < .001 and P < .001, respectively) and in cases with IDH1 mutation (100 and 198 mo, respectively) than in cases without IDH1 mutation (72 mo and not reached; P = .028 and P = .001, respectively). In multivariate analyses, spontaneous velocity of diametric expansion and IDH1 mutation were independent prognostic factors for malignant progression-free survival (P < .001; hazard ratio, 4.23; 95% CI, 1.81-9.40 and P = .019; hazard ratio, 2.39; 95% CI, 1.19-4.66, respectively) and for overall survival (P < .001; hazard ratio, 26.3; 95% CI, 5.42-185.2 and P = .007; hazard ratio, 17.89; 95% CI, 2.15-200.1, respectively). CONCLUSIONS: The spontaneous velocity of diametric expansion and IDH1 mutation status are 2 independent prognostic values that should be obtained at the beginning of the management of diffuse low-grade gliomas in adults.
Authors: G Bauman; K Lote; D Larson; L Stalpers; C Leighton; B Fisher; W Wara; D MacDonald; L Stitt; J G Cairncross Journal: Int J Radiat Oncol Biol Phys Date: 1999-11-01 Impact factor: 7.038
Authors: Emmanuel Mandonnet; Jean-Yves Delattre; Marie-Laure Tanguy; Kristin R Swanson; Antoine F Carpentier; Hugues Duffau; Philippe Cornu; Rémy Van Effenterre; Ellsworth C Alvord; Laurent Capelle Journal: Ann Neurol Date: 2003-04 Impact factor: 10.422
Authors: Francesco Pignatti; Martin van den Bent; Desmond Curran; Channa Debruyne; Richard Sylvester; Patrick Therasse; Denes Afra; Philippe Cornu; Michel Bolla; Charles Vecht; Abul B M F Karim Journal: J Clin Oncol Date: 2002-04-15 Impact factor: 44.544
Authors: Edward F Chang; Justin S Smith; Susan M Chang; Kathleen R Lamborn; Michael D Prados; Nicholas Butowski; Nicholas M Barbaro; Andrew T Parsa; Mitchel S Berger; Michael M McDermott Journal: J Neurosurg Date: 2008-11 Impact factor: 5.115
Authors: C Izquierdo; A Alentorn; A Idbaih; M Simó; G Kaloshi; D Ricard; M Barritault; D Meyronet; J Bruna; J Honnorat; J Y Delattre; F Ducray Journal: J Neurooncol Date: 2017-11-15 Impact factor: 4.130